ODI PHARMA AB Defensive Interval Ratio
ODI PHARMA AB defensive interval ratio. ODI PHARMA AB (6OD) has a Defensive Interval Ratio of 23 days as of June 2026. Defensive assets of €180.64K (cash €-, short-term investments €-, receivables €180.64K) cover 23 days of daily cash needs of €8.02K/day. See 6OD working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of ODI PHARMA AB (2022–2026)
Defensive interval ratio of ODI PHARMA AB from 2022 to 2026. This chart shows how ODI PHARMA AB's Defensive Interval Ratio has evolved across 5 annual periods from 2022 to 2026. As of June 2026, the ratio stands at 23 days, meaning defensive assets of €180.64K can fund 23 days of operations without new revenue. Read ODI PHARMA AB debt and liabilities for a breakdown of total debt and financial obligations.
ODI PHARMA AB Defensive Interval Ratio by Year (2022–2026)
ODI PHARMA AB defensive interval ratio by year from 2022 to 2026. The table below presents the year-by-year Defensive Interval Ratio for ODI PHARMA AB from 2022 to 2026, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see 6OD total asset value.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2026 | 23 days | €180.64K | €8.02K/day | €- | €- | ▲ +12 days |
| 2025 | 10 days | €115.58K | €11.47K/day | €- | €- | ▼ -278 days |
| 2024 | 288 days | €8.07 Million | €28.02K/day | €- | €- | ▲ +280 days |
| 2023 | 9 days | €132.61K | €15.38K/day | €- | €- | ▼ -23 days |
| 2022 | 32 days | €108.63K | €3.39K/day | €- | €- | — |